Skip to main content
Skip to main menu Skip to spotlight region Skip to secondary region Skip to UGA region Skip to Tertiary region Skip to Quaternary region Skip to unit footer

Slideshow

Newly discovered receptor may be key to new therapies for sleeping sickness

A discovery by UGA researchers may soon lead to new therapies for African trypanosomiasis, or sleeping sickness:

The scientists at UGA's Center for Tropical and Emerging Global Diseases discovered a specific receptor tucked away in an organelle inside the disease-causing trypanosome parasite that regulates the release of calcium, which is responsible for numerous critical cell functions required for parasite growth and replication.

"This receptor is an attractive drug target," said Roberto Docampo, Barbara and Sanford Orkin/Georgia Research Alliance Eminent Scholar and co-author of a paper describing their findings published Jan. 14 in the early edition of the Proceedings of the National Academy of Sciences. "The mechanisms we have identified are critical for the survival of the parasite, so if we can manipulate them, we can stop the infection."

The calcium receptor identified by the researchers serves as a kind of messenger within the parasite, telling it when to secrete specific chemicals, when to divide and when to spread. They hypothesized that disrupting this system would leave the parasites incapable of growing and replicating within their human and animal hosts.

Docampo and his colleagues tested their hypothesis by watching genetically modified versions of the parasitic cell both in laboratory cultures and in mice. In both cases, the genetically altered parasites with dysfunctional calcium receptors were unable to replicate, and mice in the experimental group remained disease free.

"We knew that these organelles were rich in acidic calcium, but it is not until now that we understand how they released the calcium to control cell functions," said Docampo, who is a professor of cellular biology in the UGA Franklin College of Arts and Sciences. "Now that we better understand this critical pathway, we may begin thinking about new therapies for sleeping sickness."

As the press release makes clear, sleeping sickness sounds benign enough but it is a a potentially fatal parasitic infection that has ravaged populations in sub-Saharan Africa for decades. The Center for Tropical and Emerging Diseases supports researchers who are active on a number of fronts like this - chronically neglected diseases that affect millions of people. Congratulations to Dr. Docampo and his team on this new hopeful work.

Image: UGA photo of Roberto Docampo, Barbara and Sanford Orkin/Georgia Research Alliance Eminent Scholar and a professor of cellular biology in the UGA Franklin College of Arts and Sciences. 

Support Franklin College

We appreciate your financial support. Your gift is important to us and helps support critical opportunities for students and faculty alike, including lectures, travel support, and any number of educational events that augment the classroom experience. Click here to learn more about giving.